Literature DB >> 20035587

Measuring methylphenidate response in attention-deficit/hyperactvity disorder: how are laboratory classroom-based measures related to parent ratings?

Edmund J S Sonuga-Barke1, David Coghill, Marc DeBacker, James Swanson.   

Abstract

BACKGROUND: Methylphenidate (MPH) is an efficacious and normally well-tolerated treatment for attention-deficit/hyperactivity disorder (ADHD). Although treatment effects are usually assessed using parent-rating scales, these can be supplemented by more objective methods. Here we examine the associations between ratings and one such method, assessments made across the day in the laboratory classroom.
METHOD: Comparison of Methylphenidates in the Analog Classroom Setting (COMACS) was made in a large (n = 184) placebo-controlled trial comparing Equasym XL/Metadate CD, Concerta, and placebo (PLA) using a Laboratory School protocol. Therapeutic effects were measured using direct observation, scores on a simple math productivity task and parent ratings.
RESULTS: Treatment effects were observed on all measures. Laboratory measures were correlated with each other, most strongly between Swanson, Kotkin, Agler, M-Flynn and Pelham Scale (SKAMP) inattention and Permanent Product Measure of Performance (PERMP). Parental ratings were correlated with classroom measures during the main morning period (1.5-4.5 hours after dosing) and to a lesser extent in the afternoon (6.0-7.5 hours after dosing), but not, by and large, immediately after dosing or in the evening. The morning correlations seemed stronger for female than for male participants. DISCUSSION: The results suggest that parental ratings and direct observations tap different aspects of MPH response and that both may be required for comprehensive assessment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035587     DOI: 10.1089/cap.2009.0027

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  7 in total

1.  Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta(®)--a randomized, controlled, double-blind multicenter clinical crossover trial.

Authors:  Manfred Döpfner; Claudia Ose; Roland Fischer; Richard Ammer; André Scherag
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-07-26       Impact factor: 2.576

Review 2.  A Review of the Clinical Utility of Systematic Behavioral Observations in Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Franziska Minder; Agnieszka Zuberer; Daniel Brandeis; Renate Drechsler
Journal:  Child Psychiatry Hum Dev       Date:  2018-08

Review 3.  Training cognition in ADHD: current findings, borrowed concepts, and future directions.

Authors:  Kyle J Rutledge; Wouter van den Bos; Samuel M McClure; Julie B Schweitzer
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 4.  Cogmed Working Memory Training for youth with ADHD: a closer examination of efficacy utilizing evidence-based criteria.

Authors:  Anil Chacko; Nicole Feirsen; Anne-Claude Bedard; David Marks; Jodi Z Uderman; Alyssa Chimiklis
Journal:  J Clin Child Adolesc Psychol       Date:  2013-05-13

5.  Clinical use of a modified release methylphenidate in the treatment of childhood attention deficit hyperactivity disorder.

Authors:  Inyang Takon
Journal:  Ann Gen Psychiatry       Date:  2011-09-30       Impact factor: 3.455

Review 6.  Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD.

Authors:  Lidy M Pelsser; Klaas Frankena; Jan Toorman; Rob Rodrigues Pereira
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

7.  Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Ann C Childress; Jeffrey H Newcorn; Andrew J Cutler
Journal:  Adv Ther       Date:  2019-04-10       Impact factor: 3.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.